Deseret Mutual Benefit Administrators’s Bio-Rad Laboratories Class A BIO Stock Holding History

Deseret Mutual Benefit Administrators’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10	Closed	-$2.8K	–	503
2025 Q3	$2.8K	Hold	10	–	–	﹤0.01%	505
2025 Q2	$2.41K	Hold	10	–	–	﹤0.01%	485
2025 Q1	$2.44K	Hold	10	–	–	﹤0.01%	486
2024 Q4	$3.29K	Sell	10 -4	-29%	-$1.36K	﹤0.01%	470
2024 Q3	$4.68K	Sell	14 -21	-60%	-$6.67K	﹤0.01%	479
2024 Q2	$9.56K	Hold	35	–	–	﹤0.01%	472
2024 Q1	$12.1K	Hold	35	–	–	0.01%	459
2023 Q4	$11.3K	Buy	35 +20	+133%	+$6.27K	0.01%	461
2023 Q3	$5.38K	Hold	15	–	–	﹤0.01%	488
2023 Q2	$5.69K	Buy	+15	New	+$6.1K	﹤0.01%	485

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deseret Mutual Benefit Administrators's BIO Position: Q4 2025 in Review

Deseret Mutual Benefit Administrators sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2025, closing a stake of 10 shares — an estimated $2.8K sold.

Deseret Mutual Benefit Administrators first reported a position in BIO in Q2 2023 and held it in 10 quarters. The position peaked at $12.1K in Q1 2024. 399 funds tracked by Wall St. Rank hold BIO as of Q4 2025.

Deseret Mutual Benefit Administrators reported no remaining Bio-Rad Laboratories Class A position as of Q4 2025 after selling out during the quarter.
Deseret Mutual Benefit Administrators sold 10 Bio-Rad Laboratories Class A shares in Q4 2025, an estimated $2.8K.
Deseret Mutual Benefit Administrators first reported a position in Bio-Rad Laboratories Class A in Q2 2023 and held it in 10 quarters.
Deseret Mutual Benefit Administrators's Bio-Rad Laboratories Class A position peaked at $12.1K in Q1 2024.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2025.

Based on Deseret Mutual Benefit Administrators's 13F filing for Q4 2025, filed 11 Feb 2026.